Detalles de la búsqueda
1.
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.
Biomed Pharmacother
; 176: 116857, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850664
2.
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Cancers (Basel)
; 11(10)2019 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31614664
3.
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
World J Gastroenterol
; 24(42): 4738-4749, 2018 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30479461
Resultados
1 -
3
de 3
1
Próxima >
>>